About Opertech Bio
Opertech Bio is a company based in Philadelphia (United States) founded in 2011 by Scott Horvitz and R Kyle Palmer. Opertech Bio has raised $750 thousand across 2 funding rounds from investors including Ben Franklin Technology Partners and Gabriel Investments. Opertech Bio offers products and services including TāStation®, Fee-for-Service Testing, and Licensing Services. Opertech Bio operates in a competitive market with competitors including AmiNIC and Intelligent Sensor Technology, among others.
- Headquarter Philadelphia, United States
- Founders Scott Horvitz, R Kyle Palmer
-
Sectors
ConsumerHealthcare Technology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Opertech Bio, Inc.
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$750 K (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Ben Franklin Technology Partners
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Opertech Bio
Opertech Bio offers a comprehensive portfolio of products and services, including TāStation®, Fee-for-Service Testing, and Licensing Services.
System for rapid and accurate taste analysis of samples
Provides customized taste evaluation for client products
Offers access to taste technology for industry applications
People of Opertech Bio
Unlock access to complete
Unlock access to complete
Funding Insights of Opertech Bio
Opertech Bio has successfully raised a total of $750K across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Opertech Bio
Opertech Bio has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Ben Franklin Technology Partners and Gabriel Investments.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Locked | Locked | Locked | |
|
An investment group focused on early-stage technology companies.
|
Locked | Locked | Locked |
Investor details for Opertech Bio
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Opertech Bio
Investment portfolio details for Opertech Bio
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Opertech Bio
Detailed financials for Opertech Bio
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Opertech Bio Comparisons
Peer comparison for Opertech Bio
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Opertech Bio
Opertech Bio operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AmiNIC and Intelligent Sensor Technology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Sensor devices for assessing meat and fish freshness are produced.
|
|
| Locked | Locked | Locked |
Develops taste sensing systems for various applications.
|
Detailed competitors of Opertech Bio
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Opertech Bio
Complete news archive for Opertech Bio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Opertech Bio
Opertech Bio was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Opertech Bio is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Scott Horvitz is the current CEO of Opertech Bio. They have also founded this company.
Opertech Bio is a funded company, having raised a total of $750K across 2 funding rounds to date.
Opertech Bio was founded in 2011 in Philadelphia, United States, focusing on sensory evaluation solutions for the food, beverage, and flavor ingredients sectors. The Microtiter Operant Gustometer (MOG) platform is utilized to create the automated TāStation system, which assesses taste characteristics of numerous samples in under an hour. Evaluations are conducted objectively without subjective scales, requiring only 3 to 4 human or animal subjects.
Opertech Bio's top competitors include AmiNIC and Intelligent Sensor Technology.
Opertech Bio offers TāStation®, Fee-for-Service Testing, and Licensing Services.
Opertech Bio has 2 investors. Key investors include Ben Franklin Technology Partners, and Gabriel Investments.